# Valiant Laboratories (NSE: VALIANTLAB) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/VALIANTLAB · Pivot · prices to 22 Oct 2026

Valiant Laboratories (NSE: VALIANTLAB) closed at ₹131.05 on 22 Oct 2026, down 2.00% on the day. With a market capitalisation of ₹712 Cr, it ranks 1618th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

Its return on equity was −1.1% in FY26. Over the past year the share price has risen 56.4%. Its 52-week range is ₹49.51 (4 Mar 2026) to ₹141.38 (19 Oct 2026); the last close is 7.3% below the high. Promoters held 74.94% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹131.05 |
| Market cap | ₹712 Cr |
| ROE | −1.1% (FY26) |
| ROCE | 0.8% (FY26) |
| Debt to equity | 0.14 |
| 52-week high | ₹141.38 (19 Oct 2026) |
| 52-week low | ₹49.51 (4 Mar 2026) |
| 1-year return | +56.4% |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹133 Cr | −₹2 Cr |
| FY24 | ₹182 Cr | ₹0 Cr |
| FY23 | ₹334 Cr | ₹29 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 74.94%
- Foreign institutions: 0.00%
- Domestic institutions: 0.00%
- Non-institutions: 25.06%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Kilitch Drugs (India)](https://app.pivotnow.in/stock/KILITCH) | ₹215.00 | ₹752 Cr | 24.2 | — |
| [Vikram Thermo](https://app.pivotnow.in/stock/VIKRAMTH) | — | ₹728 Cr | — | — |
| [Zim Laboratories](https://app.pivotnow.in/stock/ZIMLAB) | ₹133.50 | ₹715 Cr | 112.2 | — |
| [Amanta Healthcare](https://app.pivotnow.in/stock/AMANTA) | ₹182.55 | ₹709 Cr | 42.2 | — |
| [Gaudium IVF and Women Health](https://app.pivotnow.in/stock/GAUDIUMIVF) | ₹95.11 | ₹692 Cr | 24.3 | — |
| [Wanbury](https://app.pivotnow.in/stock/WANBURY) | ₹185.66 | ₹649 Cr | 9.6 | — |

## Questions and answers

### What is the share price of Valiant Laboratories today?

Valiant Laboratories (NSE: VALIANTLAB) last closed at ₹131.05 on 22 Oct 2026. Its 52-week high is ₹141.38 and its 52-week low is ₹49.51.

### What is the market cap of Valiant Laboratories?

Valiant Laboratories' market capitalisation is ₹712 Cr (₹712 Cr) at the 22 Oct 2026 close, ranking 1618th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Valiant Laboratories?

Return on equity was −1.1% in FY26 and return on capital employed was 0.8% in FY26 (consolidated figures).

### Is Valiant Laboratories a debt-free company?

No. Valiant Laboratories' debt-to-equity ratio was 0.14 in FY26, with total debt of ₹28 Cr.

### How has Valiant Laboratories stock performed over the last year?

Valiant Laboratories' share price has risen 56.4% over the past year, +108.7% over three months and +2.4% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Valiant Laboratories?

As of 30 Jun 2026: promoters 74.94%, foreign institutions 0.00%, domestic institutions 0.00%, non-institutions 25.06%.

### Who are Valiant Laboratories' competitors?

The listed Pharma & Healthcare companies closest to Valiant Laboratories by market cap are Kilitch Drugs (India), Vikram Thermo, Zim Laboratories, Amanta Healthcare, Gaudium IVF and Women Health and Wanbury.

### Is Valiant Laboratories a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Valiant Laboratories' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on VALIANTLAB against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.